Guerra Angela, Ticinesi Andrea, Allegri Franca, Nouvenne Antonio, Pinelli Silvana, Folesani Giuseppina, Lauretani Fulvio, Maggio Marcello, Borghi Loris, Meschi Tiziana
Geriatric Rehabilitation Department, University-Hospital of Parma, Via Antonio Gramsci 14, 43126, Parma, Italy.
Department of Clinical and Experimental Medicine, University of Parma, Via Antonio Gramsci 14, 43126, Parma, Italy.
Urolithiasis. 2016 Nov;44(6):521-528. doi: 10.1007/s00240-016-0878-5. Epub 2016 Apr 1.
Our aim was to compare the influence of maternal history of stones (MHS) and paternal history of stones (PHS) on composition of calculi and disease course in a group of patients with calcium nephrolithiasis (CN) aged between 15 and 25, the age range with the maximal influence of family history on disease expression. One-hundred thirty-five patients (68 F) with CN and one stone-forming parent were retrospectively selected from the database of our outpatient stone clinic, and categorized according to MHS or PHS. Data about stone disease course and composition of passed calculi, determined by chemical analysis or Fourier-transformed infrared spectrophotometry, were collected together with information on blood chemistry and 24-h urinary profile of lithogenic risk. The characteristics of disease course and stone composition were compared using logistic regression tests adjusted for age, sex, and BMI or analysis of covariance where appropriate. Patients with MHS (n = 46) had significantly higher urinary calcium/creatinine ratio and ammonium, a higher prevalence of urological treatments (57 vs 27 %, p < 0.001) and mixed calcium oxalate/calcium phosphate stone composition (69 vs 35 %, p = 0.002) than those with PHS. At multivariate logistic regression models, MHS was independently associated with urological treatments (OR 4.5, 95 %CI 1.9-10.7, p < 0.001) and the formation of calculi with mixed calcium oxalate/calcium phosphate composition (OR 5.8, 95 %CI 1.9-17.9, p = 0.002). The method of stone analysis did not affect this result. In conclusion, in subjects aged 15-25, MHS is associated with mixed calcium stones and with a higher risk for urological procedures, and should be, therefore, considered in the management of urolithiasis.
我们的目的是比较母亲有结石病史(MHS)和父亲有结石病史(PHS)对一组年龄在15至25岁之间的钙肾结石(CN)患者结石成分和病程的影响,该年龄范围是家族史对疾病表现影响最大的年龄段。从我们门诊结石诊所的数据库中回顾性选取了135例患有CN且有一方结石形成亲属的患者,并根据MHS或PHS进行分类。收集了有关结石病程和排出结石成分的数据(通过化学分析或傅里叶变换红外分光光度法测定),以及血液化学和24小时尿液结石形成风险概况的信息。使用针对年龄、性别和BMI进行调整的逻辑回归检验或在适当情况下使用协方差分析比较疾病病程和结石成分的特征。与有PHS的患者相比,有MHS的患者(n = 46)尿钙/肌酐比值和铵含量显著更高,泌尿外科治疗的患病率更高(57% 对27%,p < 0.001),草酸钙/磷酸钙混合结石成分的比例更高(69% 对35%,p = 0.002)。在多变量逻辑回归模型中,MHS与泌尿外科治疗独立相关(比值比4.5,95%置信区间1.9 - 10.7,p < 0.001)以及草酸钙/磷酸钙混合成分结石的形成相关(比值比5.8,95%置信区间1.9 - 17.9,p = 0.002)。结石分析方法不影响这一结果。总之,在15 - 25岁的人群中,MHS与混合性钙结石以及更高的泌尿外科手术风险相关,因此在尿石症的管理中应予以考虑。